BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15368273)

  • 1. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
    Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
    Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.
    Taylor PR; Koski GK; Paustian CC; Bailey E; Cohen PA; Moore FB; Zimmerman DH; Rosenthal KS
    Vaccine; 2010 Aug; 28(34):5533-42. PubMed ID: 20600501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
    Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
    Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
    Lau YF; Deliyannis G; Zeng W; Mansell A; Jackson DC; Brown LE
    Int Immunol; 2006 Dec; 18(12):1801-13. PubMed ID: 17077175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant.
    Nesburn AB; Ramos TV; Zhu X; Asgarzadeh H; Nguyen V; BenMohamed L
    Vaccine; 2005 Jan; 23(7):873-83. PubMed ID: 15603887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.
    Jamali A; Mahdavi M; Hassan ZM; Sabahi F; Farsani MJ; Bamdad T; Soleimanjahi H; Motazakker M; Shahabi S
    Int Immunol; 2009 Mar; 21(3):217-25. PubMed ID: 19174474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.
    Zhang X; Issagholian A; Berg EA; Fishman JB; Nesburn AB; BenMohamed L
    J Virol; 2005 Dec; 79(24):15289-301. PubMed ID: 16306600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD; Chiou HC; Hull BE; Bigley NJ
    Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
    Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.
    Goel N; Rong Q; Zimmerman D; Rosenthal KS
    Vaccine; 2003 Oct; 21(27-30):4410-20. PubMed ID: 14505924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships.
    Spohn R; Buwitt-Beckmann U; Brock R; Jung G; Ulmer AJ; Wiesmüller KH
    Vaccine; 2004 Jun; 22(19):2494-9. PubMed ID: 15193414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed TH1/TH2-like cytokine response by naive CD4+ T cells.
    Williams MA; Porter M; Horton M; Guo J; Roman J; Williams D; Breysse P; Georas SN
    J Allergy Clin Immunol; 2007 Feb; 119(2):488-97. PubMed ID: 17187851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells from Chlamydia-infected mice show altered Toll-like receptor expression and play a crucial role in inhibition of allergic responses to ovalbumin.
    Han X; Fan Y; Wang S; Yang J; Bilenki L; Qiu H; Jiao L; Yang X
    Eur J Immunol; 2004 Apr; 34(4):981-9. PubMed ID: 15048708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.